Nemaura Medical Inc. (NMRD)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.59 Million USD | -26.75% |
| 2022 | -7.57 Million USD | -65.05% |
| 2021 | -4.58 Million USD | 4.01% |
| 2020 | -4.77 Million USD | -6.74% |
| 2019 | -4.47 Million USD | -134.51% |
| 2018 | -1.9 Million USD | -23.06% |
| 2017 | -1.55 Million USD | -0.76% |
| 2016 | -1.53 Million USD | -16.65% |
| 2015 | -1.31 Million USD | -125.14% |
| 2014 | -586.23 Thousand USD | 29.42% |
| 2013 | -830.57 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.83 Million USD | 57.21% |
| 2024 Q3 | -1.54 Million USD | 24.84% |
| 2024 Q2 | -2.05 Million USD | -11.8% |
| 2023 Q2 | -1.62 Million USD | 26.52% |
| 2023 FY | -9.59 Million USD | -26.75% |
| 2023 Q4 | -4.28 Million USD | -576.87% |
| 2023 Q3 | -633.32 Thousand USD | 61.02% |
| 2023 Q1 | -2.21 Million USD | 9.48% |
| 2022 Q4 | -2.44 Million USD | -36.28% |
| 2022 Q1 | -1.62 Million USD | -17.49% |
| 2022 Q2 | -1.71 Million USD | -5.81% |
| 2022 Q3 | -1.79 Million USD | -4.52% |
| 2022 FY | -7.57 Million USD | -65.05% |
| 2021 Q3 | -1.06 Million USD | 12.98% |
| 2021 FY | -4.58 Million USD | 4.01% |
| 2021 Q4 | -1.37 Million USD | -29.1% |
| 2021 Q1 | -911.03 Thousand USD | 32.36% |
| 2021 Q2 | -1.22 Million USD | -34.77% |
| 2020 Q2 | -1.11 Million USD | 11.01% |
| 2020 Q1 | -1.25 Million USD | 22.73% |
| 2020 FY | -4.77 Million USD | -6.74% |
| 2020 Q4 | -1.34 Million USD | -27.14% |
| 2020 Q3 | -1.05 Million USD | 5.16% |
| 2019 Q1 | -771.96 Thousand USD | -35.96% |
| 2019 FY | -4.47 Million USD | -134.51% |
| 2019 Q4 | -1.62 Million USD | -74.13% |
| 2019 Q3 | -932.92 Thousand USD | 18.69% |
| 2019 Q2 | -1.14 Million USD | -48.63% |
| 2018 Q4 | -567.77 Thousand USD | -19.19% |
| 2018 Q3 | -476.35 Thousand USD | -6.44% |
| 2018 Q2 | -447.51 Thousand USD | -7.24% |
| 2018 Q1 | -417.32 Thousand USD | -16.17% |
| 2018 FY | -1.9 Million USD | -23.06% |
| 2017 FY | -1.55 Million USD | -0.76% |
| 2017 Q4 | -359.23 Thousand USD | 4.3% |
| 2017 Q3 | -375.36 Thousand USD | -16.4% |
| 2017 Q2 | -322.48 Thousand USD | 34.74% |
| 2017 Q1 | -494.18 Thousand USD | -18.31% |
| 2016 Q1 | -402.82 Thousand USD | 24.84% |
| 2016 FY | -1.53 Million USD | -16.65% |
| 2016 Q4 | -417.71 Thousand USD | -27.05% |
| 2016 Q3 | -328.78 Thousand USD | 15.76% |
| 2016 Q2 | -390.3 Thousand USD | 3.11% |
| 2015 Q4 | -535.93 Thousand USD | -237.57% |
| 2015 FY | -1.31 Million USD | -125.14% |
| 2015 Q1 | -269.25 Thousand USD | -66.07% |
| 2015 Q2 | -355.88 Thousand USD | -32.18% |
| 2015 Q3 | -158.76 Thousand USD | 55.39% |
| 2014 Q1 | -61.77 Thousand USD | 70.25% |
| 2014 Q3 | -340.19 Thousand USD | -1437.12% |
| 2014 Q4 | -162.12 Thousand USD | 52.34% |
| 2014 FY | -586.23 Thousand USD | 29.42% |
| 2014 Q2 | -22.13 Thousand USD | 64.17% |
| 2013 Q4 | -207.64 Thousand USD | 0.0% |
| 2013 FY | -830.57 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 33.185% |
| Biotricity, Inc. | -8.82 Million USD | -8.688% |
| Cell MedX Corp. | -313.43 Thousand USD | -2961.364% |
| Dynatronics Corporation | -2.27 Million USD | -322.131% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 9.661% |
| RetinalGenix Technologies Inc. | -2.08 Million USD | -359.751% |
| Sonendo, Inc. | -57.74 Million USD | 83.383% |
| Telesis Bio, Inc. | -35.15 Million USD | 72.702% |
| Talis Biomedical Corporation | -66.81 Million USD | 85.639% |
| Viveve Medical, Inc. | -21.55 Million USD | 55.481% |